Edmond DE Rothschild Holding S.A. acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 15,014 shares of the conglomerate's stock, valued at approximately $2,860,000.
A number of other institutional investors also recently bought and sold shares of the stock. Geneva Partners LLC purchased a new position in Danaher during the second quarter valued at $945,000. CM Wealth Advisors LLC purchased a new stake in Danaher in the second quarter worth about $431,000. Madison Asset Management LLC bought a new position in shares of Danaher in the second quarter worth about $85,451,000. Csenge Advisory Group purchased a new position in shares of Danaher during the 2nd quarter valued at about $441,000. Finally, AssuredPartners Investment Advisors LLC purchased a new position in shares of Danaher during the 2nd quarter valued at about $290,000. 79.05% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Wells Fargo & Company reduced their target price on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a report on Wednesday, July 22nd. Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price target for the company. Guggenheim reduced their price objective on shares of Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Royal Bank Of Canada raised their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an "outperform" rating in a research report on Wednesday, July 22nd. Finally, DZ Bank started coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a "buy" rating and a $210.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and a consensus target price of $228.91.
Get Our Latest Research Report on Danaher
Danaher Trading Up 2.2%
DHR stock opened at $216.14 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The business has a 50 day simple moving average of $195.01 and a two-hundred day simple moving average of $192.43. The company has a market capitalization of $151.94 billion, a price-to-earnings ratio of 38.39, a PEG ratio of 2.63 and a beta of 0.78.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter last year, the business posted $0.77 earnings per share. The company's revenue for the quarter was up 5.5% compared to the same quarter last year. Research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.